ZILRETTA

Triamcinolone acetonide extended-release injectable suspension · Pacira Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for ZILRETTA, covering 2017-10-06 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip [Phase 2]

See pricing